BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25367407)

  • 1. Association of COMT Val158Met polymorphism with wearing-off susceptibility in Parkinson's disease.
    Liu J; Chen P; Guo M; Lu L; Li L
    Neurol Sci; 2015 Apr; 36(4):621-3. PubMed ID: 25367407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol-O-methyltransferase Val158Met polymorphism: modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease.
    Wu H; Dong F; Wang Y; Xiao Q; Yang Q; Zhao J; Quinn TJ; Chen SD; Liu J
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1094-6. PubMed ID: 25108642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations.
    Wang YC; Zou YB; Xiao J; Pan CD; Jiang SD; Zheng ZJ; Yan ZR; Tang KY; Tan LM; Tang MS
    Neurol Res; 2019 Apr; 41(4):319-325. PubMed ID: 30644790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Val158Met polymorphism of COMT gene and Parkinson's disease risk in Asians.
    Chuan L; Gao J; Lei Y; Wang R; Lu L; Zhang X
    Neurol Sci; 2015 Jan; 36(1):109-15. PubMed ID: 25060648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease.
    de Lau LM; Verbaan D; Marinus J; Heutink P; van Hilten JJ
    Mov Disord; 2012 Jan; 27(1):132-5. PubMed ID: 22083803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
    Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
    J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catechol-O-methyltransferase gene Val158Met polymorphism and obsessive compulsive disorder susceptibility: a meta-analysis.
    Kumar P; Rai V
    Metab Brain Dis; 2020 Feb; 35(2):241-251. PubMed ID: 31879835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between COMT Val158Met polymorphism and migraine risk: A meta-analysis.
    Liao YJ; Jiang JR; Jin SQ
    Cephalalgia; 2017 May; 37(6):592-598. PubMed ID: 27154995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Catechol-O-Methyltransferase Gene rs4680 Polymorphism and Levodopa Induced Dyskinesia in Parkinson's Disease: A Meta-Analysis and Systematic Review.
    Dwivedi A; Dwivedi N; Kumar A; Singh VK; Pathak A; Chaurasia RN; Mishra VN; Mohanty S; Joshi D
    J Geriatr Psychiatry Neurol; 2023 Mar; 36(2):98-106. PubMed ID: 35603896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic denervation severity depends on COMT Val158Met polymorphism in Parkinson's disease.
    Muellner J; Gharrad I; Habert MO; Kas A; Martini JB; Cormier-Dequaire F; Tahiri K; Vidailhet M; Meier N; Brice A; Schuepbach M; Mallet A; Hartmann A; Corvol JC
    Parkinsonism Relat Disord; 2015 May; 21(5):471-6. PubMed ID: 25753458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking/COMT H158L polymorphisms with the risk of PD.
    Zhang Y; Piao X; Wu J; Li Y; Liang Q
    Int J Neurosci; 2016; 126(5):400-7. PubMed ID: 26000819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population.
    Hao H; Shao M; An J; Chen C; Feng X; Xie S; Gu Z; Chan P;
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1041-5. PubMed ID: 25034874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
    Chen Y; Yu X; Li T; Yan H; Mo Z
    Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between catechol-O-methyltransferase gene polymorphisms and wearing-off and dyskinesia in Parkinson's disease.
    Watanabe M; Harada S; Nakamura T; Ohkoshi N; Yoshizawa K; Hayashi A; Shoji S
    Neuropsychobiology; 2003; 48(4):190-3. PubMed ID: 14673217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The COMT Val158Met polymorphism as an associated risk factor for Parkinson's disease in Asian rather than Caucasian populations.
    Lechun L; Yu S; Pengling H; Changqi H
    Neurol India; 2013; 61(1):12-6. PubMed ID: 23466833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechol-O-methyltransferase Val158Met polymorphism (rs4680) is associated with pain in multiple sclerosis.
    Fernández-de-las-Peñas C; Ambite-Quesada S; Ortíz-Gutiérrez R; Ortega-Santiago R; Gil-Crujera A; Caminero AB
    J Pain; 2013 Dec; 14(12):1719-23. PubMed ID: 24290452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Val158Met functional polymorphism in the COMT gene and risk of preeclampsia in a Chinese population.
    Liang S; Liu X; Fan P; Liu R; Zhang J; He G; Liu Y; Bai H
    Arch Med Res; 2012 Feb; 43(2):154-8. PubMed ID: 22475780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients.
    Lanni C; Garbin G; Lisa A; Biundo F; Ranzenigo A; Sinforiani E; Cuzzoni G; Govoni S; Ranzani GN; Racchi M
    J Alzheimers Dis; 2012; 32(4):919-26. PubMed ID: 22890094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Catechol-O-Methyltransferase Val158Met (158G/A) Polymorphism and Suicide Susceptibility: A Meta-analysis.
    Sadeghiyeh T; Hosseini Biouki F; Mazaheri M; Zare-Shehneh M; Neamatzadeh H; Poursharif Z
    J Res Health Sci; 2017 Jun; 17(2):e00383. PubMed ID: 28676589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder.
    Rothe C; Koszycki D; Bradwejn J; King N; Deluca V; Tharmalingam S; Macciardi F; Deckert J; Kennedy JL
    Neuropsychopharmacology; 2006 Oct; 31(10):2237-42. PubMed ID: 16525418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.